Merck & Co. Inc.’s reported positive results Tuesday for a new, easier-to-administer formulation of its blockbuster cancer ...
A team of scientists has used a novel approach to identify protein degraders that target Pin1, a protein involved in pancreatic cancer development.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback